Dapagliflozin-induced Late-onset Euglycemic Diabetic Ketoacidosis

Sodium-glucose co-transporter-2 (SGLT2) inhibitors are a class of oral hypoglycemics that improve glycemic control by increasing the urinary excretion of glucose. They gained widespread popularity because they not only showed improved glycemic control but also had a favorable effect on weight loss,...

Descripción completa

Detalles Bibliográficos
Autores principales: Iqbal, Iqra, Hamid, Mohsin, Khan, Muhammad Atique Alam, Kainat, Aleesha, Tariq, Shafaq
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2019
Materias:
Endocrinology/Diabetes/Metabolism
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6897349/
https://www.ncbi.nlm.nih.gov/pubmed/31857921
http://dx.doi.org/10.7759/cureus.6089

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6897349/
https://www.ncbi.nlm.nih.gov/pubmed/31857921
http://dx.doi.org/10.7759/cureus.6089

Ejemplares similares